|
Please select Month:  October 2008
(1)
September 2008
(7)
June 2008
(3)
May 2008
(2)
April 2008
(2)
March 2008
(1)
December 2007
(1)
November 2007
(3)
October 2007
(3)
June 2007
(1)
April 2007
(3)
February 2007
(1)
January 2007
(2)
November 2006
(4)
October 2006
(3)
September 2006
(3)
August 2006
(2)
July 2006
(1)
June 2006
(3)
May 2006
(1)
April 2006
(2)
March 2006
(2)
February 2006
(4)
January 2006
(5)
December 2005
(2)
November 2005
(11)
October 2005
(8)
September 2005
(2)
August 2005
(3)
July 2005
(8)
June 2005
(3)
May 2005
(1)
April 2005
(1)
January 2005
(4)
December 2004
(14)
November 2004
(4)
October 2004
(5)
August 2004
(2)
June 2004
(1)
April 2004
(6)
November 2003
(1)
October 2003
(1)
April 2003
(1)
July 2002
(1)
February 2001
(1)
December 2000
(1)
September 2000
(1)
June 2000
(1)
|
29th July 2005
Import di principi attivi: Aschimfarma chiede norme più severe
Import di principi attivi: Aschimfarma chiede norme più severe
29th July 2005
Baccalini confermato presidente di Aschimfarma
L’Assemblea di Aschimfarma (Associazione Nazionale Materie Prime Farmaceutiche), che fa parte di Federchimica, ha eletto alla presidenza, all’unanimità, anche per il biennio 2005-2006, Gian Mario Baccalini di Zambon Group.
28th July 2005
Chinese success smells less sweet at home
The Hisun Pharmaceutical factory in Taizhou, China, is accused by neighbors of toxic dumping and by employees, like Shen Yunxiang, of unsafe work conditions. International Herald Tribune, November 5, 2003.
27th July 2005
OBJECTION REACH: Chemicals policy threatens SMEs.
“REACH threatens the existence of small and medium-sized enterprises and will lead to the loss of jobs and trainee places without significantly improving either environmental protection or consumer protection.” Erhardt Fiebiger, Managing Director, Zschimmer & Schwarz
27th July 2005
A level playing field
Guy Villax, CEO of Hovione, calls on the European authorities to inspect API producers abroad.
25th July 2005
Cheap and Deadly
Substitution of branded medicinal products by cheaper products with in principle the same efficacy is yearly causing the deaths of tens and possibly hundreds of, most elderly, people, according to the Hoofddorp general practitioner H.G. Schmit.
15th July 2005
API makers claim future at stake from unchecked Asian imports
EUROPEAN PRODUCERS of active pharmaceutical ingredients (API) are stepping up their warnings about the potentially negative effects on their future resulting from unfair competition from API manufacturers outside Europe, particularly in Asia.
5th July 2005
La chimie fine européenne regroupe ses forces dans l’EFCG
L’union fait la force. C’est le credo du nouveau groupe européen de la chimie fine qui cherche à tisser des liens entre ses membres pour les aider à résister à une concurrence asiatique féroce.
Please select the month you would like to view from the list on the left.
|
